Cryopreservation at HairClone is a process using proprietary technology to cool follicles to very low temperatures (as low as -196 °C). Any chemical activity in the follicle cells is effectively stopped and cells enter a state of ‘suspended animation’. Follicles can be stored for many years and when appropriately thawed, their cells resume normal function.

HairClone aims to begin clinical work in the UK in 2024. The goal is to optimise the clinical process and find the most effective treatment method. Based on results, clinicians in the UK can prescribe treatment using HairClone’s ‘Cell Expansion Service’. Our physician partners will work closely with our UK physicians to give access to those outside the UK.

Results of this clinical work will be used to inform a multi-centre, international clinical trial with the aim of eventually offering treatments worldwide.

We will do our utmost with the financial resources available to offer this therapy as quickly and efficiently as possible.

No! Many scientific advancements have been made through the use of animal studies; however, human hair is unique and cannot be readily modelled in animals. HairClone use human tissue and advanced omics techniques to translate laboratory findings directly into the clinic. This approach precludes the need to demonstrate efficacy in animal studies.